soluble mog35-55i-ab dimers ameliorate experimental autoimmune encephalomyelitis by reducing encephalitogenic t cells实验性自身免疫性脑脊髓炎可溶性mog35-55i-ab二聚体改善减少encephalitogenic t细胞.pdfVIP

  • 4
  • 0
  • 约7.58万字
  • 约 11页
  • 2017-09-09 发布于上海
  • 举报

soluble mog35-55i-ab dimers ameliorate experimental autoimmune encephalomyelitis by reducing encephalitogenic t cells实验性自身免疫性脑脊髓炎可溶性mog35-55i-ab二聚体改善减少encephalitogenic t细胞.pdf

soluble mog35-55i-ab dimers ameliorate experimental autoimmune encephalomyelitis by reducing encephalitogenic t cells实验性自身免疫性脑脊髓炎可溶性mog35-55i-ab二聚体改善减少encephalitogenic t细胞

Soluble MOG35-55/I-Ab Dimers Ameliorate Experimental Autoimmune Encephalomyelitis by Reducing Encephalitogenic T Cells Yeli Gong, Zhigang Wang, Zhihui Liang, Hongxia Duan, Lichen Ouyang, Qian Yu, Zhe Xu, Guanxin Shen, Xiufang Weng*, Xiongwen Wu* Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China Abstract The MOG35-55 peptide-induced experimental autoimmune encephalomyelitis (EAE) model in C57BL/6 mice is a useful animal model to explore therapeutic approaches to T cell-mediated autoimmune

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档